nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorcyclizine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.16	0.19	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0436	0.0518	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0427	0.0507	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0367	0.0435	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0359	0.0426	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0259	0.0307	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0249	0.0296	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0241	0.0286	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0233	0.0277	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0229	0.0272	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0226	0.0269	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0218	0.0258	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0211	0.025	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0202	0.024	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0196	0.0233	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0193	0.0229	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.019	0.0226	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0177	0.021	CbGpPWpGaD
Chlorcyclizine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0148	0.0175	CbGpPWpGaD
Chlorcyclizine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0124	0.0147	CbGpPWpGaD
Chlorcyclizine—Azelastine—HRH3—attention deficit hyperactivity disorder	0.00968	0.0615	CrCbGaD
Chlorcyclizine—Mirtazapine—HRH3—attention deficit hyperactivity disorder	0.00885	0.0563	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00842	0.00999	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00825	0.00979	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00819	0.00972	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—ADRA2C—attention deficit hyperactivity disorder	0.00808	0.0514	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00721	0.00856	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00707	0.00839	CbGpPWpGaD
Chlorcyclizine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.00594	0.0377	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00572	0.00678	CbGpPWpGaD
Chlorcyclizine—Mazindol—SLC6A3—attention deficit hyperactivity disorder	0.00569	0.0362	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00549	0.00652	CbGpPWpGaD
Chlorcyclizine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00541	0.0344	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00538	0.00639	CbGpPWpGaD
Chlorcyclizine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00528	0.00626	CbGpPWpGaD
Chlorcyclizine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.00502	0.0319	CrCbGaD
Chlorcyclizine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.005	0.0318	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.005	0.00593	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0049	0.00581	CbGpPWpGaD
Chlorcyclizine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.00472	0.03	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00465	0.00551	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00463	0.00549	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0045	0.00534	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00442	0.00525	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—DRD4—attention deficit hyperactivity disorder	0.00438	0.0279	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00437	0.00518	CbGpPWpGaD
Chlorcyclizine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.00434	0.0276	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00428	0.00508	CbGpPWpGaD
Chlorcyclizine—Mazindol—SLC6A4—attention deficit hyperactivity disorder	0.00426	0.0271	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0042	0.00499	CbGpPWpGaD
Chlorcyclizine—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.00415	0.0264	CrCbGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00407	0.00483	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00398	0.00472	CbGpPWpGaD
Chlorcyclizine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.00396	0.0252	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00386	0.00457	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00379	0.0045	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—DRD3—attention deficit hyperactivity disorder	0.00378	0.024	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00374	0.00444	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00373	0.00443	CbGpPWpGaD
Chlorcyclizine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00369	0.00438	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—SLC6A3—attention deficit hyperactivity disorder	0.00352	0.0224	CrCbGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00349	0.00414	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—ADRA2A—attention deficit hyperactivity disorder	0.00345	0.0219	CrCbGaD
Chlorcyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0033	0.00391	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00326	0.00387	CbGpPWpGaD
Chlorcyclizine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00315	0.02	CrCbGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0031	0.00368	CbGpPWpGaD
Chlorcyclizine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00307	0.0195	CrCbGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00304	0.00361	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00303	0.0036	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00294	0.00348	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00289	0.00342	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00285	0.00338	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00285	0.00338	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00282	0.00335	CbGpPWpGaD
Chlorcyclizine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.00278	0.0177	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00276	0.00328	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00265	0.00315	CbGpPWpGaD
Chlorcyclizine—Mirtazapine—SLC6A4—attention deficit hyperactivity disorder	0.00263	0.0167	CrCbGaD
Chlorcyclizine—Mirtazapine—DRD2—attention deficit hyperactivity disorder	0.00262	0.0166	CrCbGaD
Chlorcyclizine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.00258	0.0164	CrCbGaD
Chlorcyclizine—Loxapine—DRD4—attention deficit hyperactivity disorder	0.00256	0.0163	CrCbGaD
Chlorcyclizine—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.00254	0.0161	CrCbGaD
Chlorcyclizine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.00253	0.0161	CrCbGaD
Chlorcyclizine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00248	0.00295	CbGpPWpGaD
Chlorcyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00244	0.0029	CbGpPWpGaD
Chlorcyclizine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00235	0.015	CrCbGaD
Chlorcyclizine—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.00227	0.0144	CrCbGaD
Chlorcyclizine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.00221	0.0141	CrCbGaD
Chlorcyclizine—Loxapine—DRD3—attention deficit hyperactivity disorder	0.00221	0.014	CrCbGaD
Chlorcyclizine—Loxapine—DRD1—attention deficit hyperactivity disorder	0.00217	0.0138	CrCbGaD
Chlorcyclizine—Clozapine—DRD4—attention deficit hyperactivity disorder	0.00215	0.0137	CrCbGaD
Chlorcyclizine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00213	0.0135	CrCbGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00211	0.0025	CbGpPWpGaD
Chlorcyclizine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.00205	0.013	CrCbGaD
Chlorcyclizine—Mirtazapine—HTR2A—attention deficit hyperactivity disorder	0.00202	0.0128	CrCbGaD
Chlorcyclizine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.00201	0.0128	CrCbGaD
Chlorcyclizine—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.00196	0.0125	CrCbGaD
Chlorcyclizine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00194	0.0023	CbGpPWpGaD
Chlorcyclizine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.00193	0.0123	CrCbGaD
Chlorcyclizine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.00192	0.0122	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00191	0.00227	CbGpPWpGaD
Chlorcyclizine—Clozapine—HTR1B—attention deficit hyperactivity disorder	0.00191	0.0121	CrCbGaD
Chlorcyclizine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00186	0.00221	CbGpPWpGaD
Chlorcyclizine—Clozapine—DRD3—attention deficit hyperactivity disorder	0.00185	0.0118	CrCbGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00184	0.00219	CbGpPWpGaD
Chlorcyclizine—Clozapine—DRD1—attention deficit hyperactivity disorder	0.00182	0.0116	CrCbGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00171	0.00203	CbGpPWpGaD
Chlorcyclizine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.00169	0.0107	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00167	0.00199	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.00198	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00166	0.00197	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00163	0.00194	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00163	0.00194	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00161	0.00191	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0016	0.0019	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00156	0.00185	CbGpPWpGaD
Chlorcyclizine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.00154	0.00976	CrCbGaD
Chlorcyclizine—Loxapine—DRD2—attention deficit hyperactivity disorder	0.00153	0.0097	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00151	0.00179	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0015	0.00178	CbGpPWpGaD
Chlorcyclizine—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.00149	0.00944	CrCbGaD
Chlorcyclizine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00148	0.00176	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00146	0.00174	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00136	0.00162	CbGpPWpGaD
Chlorcyclizine—Clozapine—DRD2—attention deficit hyperactivity disorder	0.00128	0.00815	CrCbGaD
Chlorcyclizine—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.00118	0.0075	CrCbGaD
Chlorcyclizine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Chlorcyclizine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00125	CbGpPWpGaD
Chlorcyclizine—Clozapine—HTR2A—attention deficit hyperactivity disorder	0.000991	0.0063	CrCbGaD
Chlorcyclizine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000988	0.00117	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000954	0.00113	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000919	0.00109	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00089	0.00106	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000875	0.00104	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000864	0.00103	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000805	0.000955	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000564	0.000669	CbGpPWpGaD
Chlorcyclizine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000299	0.000354	CbGpPWpGaD
